Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 272Terminated 85Recruiting 71Unknown 55Active not recruiting 37Withdrawn 25Not yet recruiting 11Enrolling by invitation 3Suspended 1No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 3Neoplasm, Residual 1

Interventions

Cytarabine 3venetoclax 1ibrutinib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1Melphalan 1JNJ-64619178 1JNJ-64264681 1Inosine Monophosphate 1Dexamethasone 1Daunorubicin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Leukemia, Myeloid, Acute × Cytarabine × Clear all
NCT07537257 2026-04-17

VEN+IDAC vs IDAC in AML

Guangdong Second Provincial General Hospital

Phase 2/3 Enrolling by invitation
232 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT06697327 2025-05-14

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Anhui Medical University

Phase NA Enrolling by invitation
94 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03507842 2025-03-17

A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML.

Asan Medical Center

Phase 3 Enrolling by invitation
380 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡